Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $300.78 million. The enterprise value is $638.78 million.
| Market Cap | 300.78M |
| Enterprise Value | 638.78M |
Important Dates
The last earnings date was Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 51.42 million shares outstanding. The number of shares has decreased by -7.67% in one year.
| Current Share Class | 51.42M |
| Shares Outstanding | 51.42M |
| Shares Change (YoY) | -7.67% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 4.32% |
| Owned by Institutions (%) | 88.54% |
| Float | 49.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.69 |
| PS Ratio | 0.46 |
| Forward PS | 0.41 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 4.96 |
| P/FCF Ratio | 1.60 |
| P/OCF Ratio | 1.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.08, with an EV/FCF ratio of 3.39.
| EV / Earnings | n/a |
| EV / Sales | 0.98 |
| EV / EBITDA | 5.08 |
| EV / EBIT | 16.94 |
| EV / FCF | 3.39 |
Financial Position
The company has a current ratio of 4.58, with a Debt / Equity ratio of 1.64.
| Current Ratio | 4.58 |
| Quick Ratio | 2.08 |
| Debt / Equity | 1.64 |
| Debt / EBITDA | 4.09 |
| Debt / FCF | 2.73 |
| Interest Coverage | 0.83 |
Financial Efficiency
Return on equity (ROE) is -58.21% and return on invested capital (ROIC) is 5.23%.
| Return on Equity (ROE) | -58.21% |
| Return on Assets (ROA) | 1.92% |
| Return on Invested Capital (ROIC) | 5.23% |
| Return on Capital Employed (ROCE) | 4.32% |
| Weighted Average Cost of Capital (WACC) | 10.62% |
| Revenue Per Employee | $721,222 |
| Profits Per Employee | -$289,667 |
| Employee Count | 900 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.15 |
Taxes
In the past 12 months, EBS has paid $20.70 million in taxes.
| Income Tax | 20.70M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.02% in the last 52 weeks. The beta is 2.29, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 2.29 |
| 52-Week Price Change | -42.02% |
| 50-Day Moving Average | 6.52 |
| 200-Day Moving Average | 7.91 |
| Relative Strength Index (RSI) | 38.42 |
| Average Volume (20 Days) | 1,136,040 |
Short Selling Information
The latest short interest is 9.68 million, so 18.84% of the outstanding shares have been sold short.
| Short Interest | 9.68M |
| Short Previous Month | 9.79M |
| Short % of Shares Out | 18.84% |
| Short % of Float | 19.74% |
| Short Ratio (days to cover) | 8.86 |
Income Statement
In the last 12 months, EBS had revenue of $649.10 million and -$260.70 million in losses. Loss per share was -$5.04.
| Revenue | 649.10M |
| Gross Profit | 281.80M |
| Operating Income | 37.70M |
| Pretax Income | -240.00M |
| Net Income | -260.70M |
| EBITDA | 125.70M |
| EBIT | 37.70M |
| Loss Per Share | -$5.04 |
Balance Sheet
The company has $175.70 million in cash and $513.70 million in debt, with a net cash position of -$338.00 million or -$6.57 per share.
| Cash & Cash Equivalents | 175.70M |
| Total Debt | 513.70M |
| Net Cash | -338.00M |
| Net Cash Per Share | -$6.57 |
| Equity (Book Value) | 313.20M |
| Book Value Per Share | 6.11 |
| Working Capital | 436.20M |
Cash Flow
In the last 12 months, operating cash flow was $200.10 million and capital expenditures -$11.70 million, giving a free cash flow of $188.40 million.
| Operating Cash Flow | 200.10M |
| Capital Expenditures | -11.70M |
| Depreciation & Amortization | 88.00M |
| Net Borrowing | -178.60M |
| Free Cash Flow | 188.40M |
| FCF Per Share | $3.66 |
Margins
Gross margin is 43.41%, with operating and profit margins of 5.81% and -40.16%.
| Gross Margin | 43.41% |
| Operating Margin | 5.81% |
| Pretax Margin | -36.97% |
| Profit Margin | -40.16% |
| EBITDA Margin | 19.37% |
| EBIT Margin | 5.81% |
| FCF Margin | 29.02% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.67% |
| Shareholder Yield | 7.67% |
| Earnings Yield | -86.07% |
| FCF Yield | 62.64% |
Analyst Forecast
The average price target for EBS is $11.00, which is 88.03% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.00 |
| Price Target Difference | 88.03% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -5.44% |
| EPS Growth Forecast (3Y) | 0.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.2 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.2 |
| Piotroski F-Score | 4 |